City Capital Llc Bay City C... Net Worth

The estimated Net Worth of City Capital Llc Bay City C... is at least $45.1 Millón dollars as of 24 July 2015. City C owns over 635,702 units of Imara Inc stock worth over $35,542,511 and over the last 15 years City sold IMRA stock worth over $9,537,283.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

City C IMRA stock SEC Form 4 insiders trading

City has made over 5 trades of the Imara Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently City sold 635,702 units of IMRA stock worth $2,199,529 on 24 July 2015.

The largest trade City's ever made was buying 23,824,450 units of Imara Inc stock on 30 June 2010 worth over $6,670,846. On average, City trades about 3,653,381 units every 264 days since 2009. As of 24 July 2015 City still owns at least 5,623,815 units of Imara Inc stock.

You can see the complete history of City C stock trades at the bottom of the page.

Insiders trading at Imara Inc

Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H y Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.

What does Imara Inc do?

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.

Complete history of City C stock trades at Sunesis Pharmaceuticals Inc y Imara Inc

Imara Inc executives and stock owners

Imara Inc executives and other stock owners filed with the SEC include:

• Rahul D. Ballal,
  Chief Executive Officer
• Edward R. Conner,
  Director
• Enterprise Associates 14, L...,
  
• Springs Capital Management ...,
  
• Lundbeck A S H,
  10% owner
• City Capital Llc Bay City C...,
  
• Venture Investments, Llc Al...,
  10% owner
• Invest A/S Lundbeckfond,
  10% owner
• Bioscience Plc Arix Bioscie...,
  
• Capital Management, L.P.Ra ...,
  
• Advisors Llc Orbi Med Capit...,
  
• James G Mc Arthur,
  Director
• Carlbay City Capital Llc Ba...,
  
• Mette Kirstine Agger,
  Director
• David P Bonita,
  Director
• Barbara Dalton,
  Director
• Sara M. Nayeem,
  Director
• David M Mott,
  Director
• Inc Pfizer Ventures (Us) Ll...,
  
• Enterprise Associates 14, L...,
  
• Michael Gray,
  CFO & COO
• Kenneth Attie,
  SVP, CMO
• Laura A Williams,
  Director
• Carl Goldfischer,
  Director
• Mark Chin,
  Director
• Advisors Llc Orbi Med Capit...,
  
• Braden Michael Leonard,
  10% owner
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Capital Lp Commodore,
  10% owner